Pharmaceutical

We bring high-value technologies designed to solve critical, analytical problems. We enable profound discoveries, optimize lab operations and ensure regulatory compliance. We help customers turn global industry challenges into the medicines that offer hope.

  • Safeguard HPLC Data Quality with Planned Performance Maintenance

    Reproducible, accurate data is critical for making key decisions about your products and obtaining important insights into your research. Learn how to safeguard your data quality by ensuring your HPLC instrument remains consistently in peak condition.

  • Biopharma’s Future: Next-Generation LC-MS Workflows for Peptide MAM

    The development of biotherapeutics continues to accelerate with their potential to revolutionize disease treatment in areas not adequately addressed by small molecule therapeutics. However, the complexity of these macromolecules and the range of potential modification variants (attributes) creates an interesting analytical challenge for scientists tasked with their characterization and then with monitoring those attributes important…

  • Embracing Analytical Techniques Into Regulated Laboratories

    To ensure compliance success in a changing regulatory landscape, laboratories must continually adapt. Learn how the compliant-ready Waters BioAccord LC-MS platform helps biopharma address the additional compliance challenges posed by the field’s complex analytical instruments.

  • Comprehending COVID-19: How Consumables Can Increase LC-MS/MS Sensitivity

    During 2020, we collaborated with many of our customers to develop targeted liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS) methods to detect SARS-CoV-2 (the virus that causes COVID-19) from biological samples. However, the combination of the biological specimen, the sample collection medium, the viral load threshold, and the need for a high throughput method gave rise to…

  • Answering the Call with Compliance-Ready LC-MS Solutions for Oligonucleotide Analysis

    Oligonucleotides, or short strands of DNA or RNA, continue to increase in popularity. In addition to their essential role as primers and probes in the expanding clinical DNA testing and diagnostics market, they’re also seeing great success as new gene-based therapeutics that hold tremendous promise. With a string of recent drug approvals, including the first…

  • Boosting Biopharma Productivity with Routine LC-MS

    As scientific advances continue to carry researchers into new arenas, it is vital that technology evolves in tandem. At Waters, we understand that it is only by leveraging fit-for-purpose technologies that researchers are able to unleash their creativity and make pioneering scientific breakthroughs. Scientists working within the rapidly growing biopharmaceutical industry are no exception. With…